¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neonatal pulmonary venous hypertension"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® neonatal intensive care center ÇÑ±Û ½Å»ý¾Æ ÁýÁßÄ¡·á½Ç
¼³¸í   
  ¹Ì¼÷¾Æ³ª °¡»ç »óÅÂÀÇ Ãâ»ê¾Æ¸¦ ÁýÁßÀûÀ¸·Î º¸»ìÇǰí Ä¡·áÇϴ ±â°ü.
¿µ¹® hypertension ÇÑ±Û °íÇ÷¾Ð
¼³¸í   
  µ¿¸ÆÀÇ Ç÷¾ÐÀÌ ³ôÀº °Í. ÀϹÝÀûÀ¸·Î ¸»Çϴ °íÇ÷¾ÐÀº ÀÌ µ¿¸Æ¼º °íÇ÷¾ÐÀ» ¸»ÇÑ´Ù. Ç÷¾ÐÀ̶õ Ç÷°ü¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»Çϴ °ÍÀ¸·Î ´ë°³ Æ¯ÀÌÇÑ ¼³¸íÀÌ ¾øÀ¸¸é µ¿¸ÆÀÇ ¾Ð·ÂÀ» ¸»ÇÑ´Ù. Ç÷¾Ð¿¡´Â ¼öÃà±âÇ÷¾Ð°ú À̿ϱâÇ÷¾ÐÀÌ ÀÖ´Ù. ¼öÃà±âÇ÷¾ÐÀ̶õ ½ÉÀåÀÌ ¼öÃàÇÒ ¶§ÀÇ µ¿¸Æ¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»Çϰí À̿ϱâ Ç÷¾ÐÀ̶õ ½ÉÀåÀÌ ÀÌ¿ÏÇÒ °æ¿ì¿¡ µ¿¸Æ¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»ÇÑ´Ù. ´ç¿¬È÷ ¼öÃà±â Ç÷¾ÐÀÌ À̿ϱâ Ç÷¾Ðº¸´Ù ³ô´Ù. Ç÷¾ÐÀ» ¸»ÇÒ ¶§¿¡ 120/80À̶ó°í Àû´Â °ÍÀÇ ¾ÕÀÇ °ÍÀº ¼öÃà±â Ç÷¾ÐÀ» ÀǹÌÇÏ°í µÚ¿¡ Àû´Â 80Àº À̿ϱâ Ç÷¾ÐÀ» ÀǹÌÇÑ´Ù.
  
  °íÇ÷¾ÐÀº ÁַΠÀ̿ϱâÀÇ Ç÷¾ÐÀ» ±âÁØÀ¸·Î Á¤ÇÑ´Ù. ¿©·¯ °¡Áö ±âÁØÀÌ ÀÖÀ¸³ª À̿ϱâ Ç÷¾ÐÀÌ 90mmHgÀÌ»óÀΠ°æ¿ì¸¦ ¸»ÇÑ´Ù. °íÇ÷¾Ð ÀÚü¿¡ ÀÇÇÑ Áõ»óÀº º°·Î ¾ø´Ù. ´Ù¸¸ °íÇ÷¾Ð¿¡ ÀÇÇÑ ÇÕº´Áõ°ú µ¿¸Æ°æÈ­ÀÇ ÃËÁø¿¡ ÀÇÇØ º´¹ßÇϴ Áúȯ¿¡ ÀÇÇÏ¿© Áõ»óÀÌ »ý±ä´Ù. °íÇ÷¾Ð¿¡ ÀÇÇÑ ÇÕº´ÁõÀº ´ë°³ Ç÷°ü¿¡ °É¸®´Â °úµµÇÑ ¾Ð·ÂÀ¸·Î ÀÎÇÑ Ç÷°üÀÇ ¼Õ»óÀÌ Áß¿äÇÑ ¿øÀÎÀÌ´Ù.
  
  °íÇ÷¾ÐÀº µ¿¸Æ°æÈ­ÀÇ ÁÖ¿ä À¯¹ßÀÎÀÚ ÁßÀÇ ÇϳªÀÌ´Ù. µ¿¸Æ°æÈ­´Â µ¿¸ÆÀÇ º®ÀÌ µÎÅÍ¿öÁö°í µ¿¸ÆÀ̠ź·ÂÀ» ÀÒ¾î¹ö¸®´Â ÁúȯÀÌ´Ù. ¾î¶² µ¿¸ÆÀÌ µ¿¸Æ°æÈ­¿¡ °É¸®¸é ÀÌ µ¿¸ÆÀº µÎÅÍ¿öÁø Ç÷°üº®¿¡ ÀÇÇØ¼­ ³»°æÀÌ ÀÛ¾ÆÁö°Ô µÈ´Ù. ÀÌ·¸°Ô µÇ¸é ±× µ¿¸ÆÀ¸·ÎºÎÅÍ Ç÷¾×À» °ø±Þ¹Þ´ø Àå±â´Â Ç÷¾×À» Àû°Ô °ø±Þ¹Þ°Ô µÇ°í ±× Á¤µµ°¡ ½ÉÇϰԠµÇ¸é ±× Àå±â´Â °á±¹ ¼Õ»óÀ» ÀÔ°Ô µÈ´Ù. µ¿¸Æ°æÈ­·Î ÀÎÇÑ Áúº´ÀÇ ´ëÇ¥ÀûÀΠ¿¹´Â ½ÉÀåÀÇ ±ÙÀ°¿¡ Ç÷¾×À» °ø±ÞÇϴ ½ÉÀ嵿¸Æ¿¡ µ¿¸Æ°æÈ­ÀÇ º¯È­°¡ ¿À´Â ½ÉÀ嵿¸Æº´ÀÌ´Ù.
  
  °íÇ÷¾ÐÀÇ Ä¡·á¿¡ ¾²À̴ ¾à¹°Àº ´ÙÀ½°ú °°Àº °ÍÀÌ ÀÖ´Ù.
  
  -ÀÌ´¢Á¦-ÄáÆÏ¿¡¼­ ¼öºÐ°ú ÀüÇØÁúÀÇ ¹èÃâÀ» ÃËÁø½Ã۴ ¾à¹°. Ã¼³»ÀÇ ¼öºÐÀÇ ¾çÀ» °¨¼Ò½ÃÄѼ­ Ç÷¾×ÀÇ È帣´Â ¾çÀ» Àû°ÔÇÏ°í ¶Ç Ç÷°üÁÖÀ§ Á¶Á÷ÀÇ ¼öºÐÀÇ °¨¼Ò·Î Ç÷°üÀ» È®Àå½Ã۴ ¿ªÇÒ(Ç÷°üÀÌ ÀÖ°í ±× Ç÷°üÀ» ½×°í Àִ Á¶Á÷¿¡ ¼öºÐÀÌ Â÷ ÀÖÀ¸¸é ±× Á¶Á÷ÀÌ Ç÷°üÀ» ´­·¯¼­ Ç÷°üÀÌ È®ÀåÇϴ °ÍÀ» ¹æÇØÇÑ´Ù)·Î Ç÷¾ÐÀ» °¨¼Ò½ÃŲ´Ù.
  
  -Ä®½·-Åë·ÎÂ÷´ÜÁ¦£­¸ðµç ±ÙÀ°ÀÇ ¼öÃà¿¡´Â Ä®½·ÀÌ ÇÊ¿äÇÏ´Ù. Áï Ç÷°üÀÇ ¼öÃà¿¡ °ü¿©Çϴ Ç÷°üµµ ¿ª½Ã ¼öÃàÀ» À§Çؼ­´Â Ä®½·ÀÌ ÇÊ¿äÇÏ´Ù. Ä®½·-Åë·ÎÂ÷´ÜÁ¦´Â ±ÙÀ°¼¼Æ÷ ¼ÓÀ¸·Î Ä®½·ÀÌ µé¾î°¡´Â °ÍÀ» ¹æÁöÇØ¼­ Ç÷°ü±ÙÀ°ÀÇ ¼öÃàÀ» ¹æÇØÇϰí À̷ΠÀÎÇØ¼­ Ç÷°üÀÇ È®ÀåÀ» À¯µµÇÑ´Ù.
  
  -¾ËÆÄÂ÷´ÜÁ¦, º£Å¸Â÷´ÜÁ¦-Ç÷°üÀº ÀÚÀ²½Å°æ°èÀÇ Áö¹è¸¦ ¹Þ´Â´Ù. ±×Áß¿¡¼­µµ Ç÷°üÀº ±³°¨½Å°æÀÇ ¿µÇâ¿¡ ÀÇÇØ¼­ ¼öÃà°ú ÀÌ¿ÏÀ» ÇÑ´Ù. ±³°¨½Å°æÀÇ ÀÛ¿ëÀº ±× ¼ö¿ëü¿¡ µû¶ó ´Þ¶óÁø´Ù. ±³°¨½Å°æÀÇ ¼ö¿ëüÀÇ Á¾·ù¿¡´Â ¾ËÆÄ¼ö¿ëü¿Í º£Å¸¼ö¿ëü°¡ ÀÖ´Ù. Ç÷°üÀ» Áö¹èÇϰí Àִ ±³°¨½Å°æ¿¡¼­ ¾ËÆÄ¼ö¿ëü´Â Ç÷°üÀÇ ¼öÃàÀ» ÀÏÀ¸Å°°í º£Å¸¼ö¿ëü´Â Ç÷°üÀÇ È®ÀåÀ» ÀÏÀ¸Å²´Ù. ±×·¯¹Ç·Î ¾ËÆÄ¼ö¿ëüÀÇ ÀÛ¿ëÀ» ¸·´Â °æ¿ì¿¡ Ç÷°üÀÇ È®ÀåÀ» À¯µµÇÒ ¼ö ÀÖ°í º£Å¸-¼ö¿ëüÀÇ ÀÛ¿ëÀ» Ç×Áø½Ãų °æ¿ì¿¡ ¿ª½Ã Ç÷°üÀÇ È®Á¤À» À¯µµÇÒ ¼ö ÀÖ´Ù.
¿µ¹® renal hypertension ÇÑ±Û ÄáÆÏ¼º°íÇ÷¾Ð
¼³¸í   
  ÄáÆÏ½ÇÁúÀÇ º´º¯À¸·Î ÀÎÇØ ¾ß±âµÈ °íÇ÷¾Ð. ÄáÆÏÀÇ ´ëÇ¥Àû ±â´ÉÀº ³ëÆó¹° ¹× ¼öºÐÀÇ ¹è¼³ÀÌ´Ù. ±×·±µ¥ ÀÌ·¯ÇÑ ÄáÆÏ±â´É¿¡ ÀÌ»óÀÌ »ý°åÀ» °æ¿ì Ã¼³»¿¡ °úÀ×¼öºÐÀÇ ÃàÀûÀÌ ¹ß»ýÇϰԠµÈ´Ù. À̿Ͱ°Àº °úÀ×¼öºÐÀÇ ÃàÀûÀº Ç÷°ü³» Á¤¼ö¾ÐÀ» »ó½Â½ÃÄÑ °íÇ÷¾ÐÀ» À¯¹ßÇϰԠµÈ´Ù. Ä¡·á´Â ¿øÀΠÄáÆÏº´ÀÇ ±³Á¤À̸ç ÀÌÀ¯¸¦ ¸ð¸£´Â ¿ø¹ß°íÇ÷¾Ð°ú ´Þ¸® ÄáÆÏ¼º°íÇ÷¾ÐÀÇ °æ¿ì¿¡´Â ¿øÀΠÄáÆÏº´ÀÌ ±³Á¤µÇ¸é °íÇ÷¾Ðµµ »ç¶óÁö°Ô µÈ´Ù.
¿µ¹® chronic obstructive pulmonary disease ÇÑ±Û ¸¸¼ºÆó¼âÆóº´
¼³¸í   
  ¸¸¼ºÀûÀ¸·Î ±âµµÀÇ Æó¼â¸¦ °¡Á®¿À´Â º´À» À̸£´Â ¸». ´ë°³ ¸¸¼º±â°üÁö¿°, ±â°üÁö Ãµ½Ä, Æó±âÁ¾ÀÇ 3°¡Áö º´À» ¸»ÇÑ´Ù.
  
  ¸¸¼º±â°üÁö¿°À̶õ ±â°üÁöÀÇ ¸¸¼º¿°ÁõÀ» ¸»ÇÑ´Ù. ±â°üÁöÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼­ ±â°üÁöÀÇ Á¡¸·¿¡ ºÎÁ¾ÀÌ »ý±â°í À̷ΠÀÎÇØ¼­ ±â°üÁöÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼­ ±âµµÀÇ Æó¼â¸¦ °¡Á®¿Â´Ù. ´ë°³ Èí¿¬°ú ¹ÐÁ¢ÇÑ ¿¬°üÀ» °¡Áö¸ç, È£Èí°ï¶õ, ±âħ, ±×¸®°í °¡·¡(´ë°³ »öÀ̠Ǫ¸£°í Á¡µµ°¡ ³ôÀº °¡·¡)°¡ Áõ»óÀ¸·Î ³ªÅ¸³­´Ù.
  
  Æó±âÁ¾Àº ±â°üÁöÀÇ º®À» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ ±â°üÁö°¡ Á¦ ¸ð¾çÀ» °®ÃßÁö ¸øÇÏ°í ¹«³ÊÁö°Ô µÇ¾î ±âµµÀÇ Æó¼â°¡ ÀϾ´Â º´ÀÌ´Ù. Áï ±â°üÁö°¡ °ü ¸ð¾çÀ¸·Î ÆØÆØÇϰԠÆìÁö´Â °ÍÀ» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ °ü¸ð¾çÀ¸·Î ÆìÁöÁö ¸øÇØ °á±¹Àº ÆóÆ÷³»¿¡ °ø±â°¡ Â÷°í ÆóÆ÷º®ÀÌ ÆÄ¿­µÇ°í ±â°üÁö°¡ Á¼¾ÆÁö°Ô µÇ´Â º´À» ¸»ÇÑ´Ù.
  
  ±â°üÁöõ½ÄÀ̶õ ¿©·¯ °¡Áö Àڱؿ¡ ´ëÇØ¼­ ±â°üÁö°¡ °ú¹ÎÇÑ ¹ÝÀÀÀ» º¸¿©¼­ »ý±â´Â ±â°üÁöÀÇ °¡¿ªÀûÀΠÆó¼â¸¦ ÀǹÌÇÑ´Ù. Áï Á¤»óÀο¡°Ô¼­´Â ±â°üÁöÀÇ Æó¼â¸¦ º¸ÀÌÁö ¾Ê´Â Àڱؿ¡ ´ëÇØ¼­ ±â°üÁöÀÇ Æó¼â°¡ »ý±â°í ±× ÀÚ±ØÀÌ ¾øÀ» °æ¿ì¿¡´Â ±â°üÁöÀÇ Æó¼â°¡ ¾ø¾îÁö´Â º´À» ¸»ÇÑ´Ù. 
¿µ¹® pulmonary function tests ÇÑ±Û Æó±â´É °Ë»ç
¼³¸í   
  ¿©·¯ °¡Áö ±â±¸¸¦ ÀÌ¿ëÇØ Æó¿ëÀû ¹× ÇãÆÄÀÇ È®»ê´ÉÀ» ¾Ë¾Æº¸´Â °Ë»ç·Î ¸» ±×´ë·Î ÇãÆÄÀÇ ±â´ÉÀ» ÃøÁ¤Çϴ °Ë»çÀÌ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄµ¿¸Æ°íÇ÷¾Ð
  • early neonatal mortality rate
    Á¶±â½Å»ý¾Æ»ç¸Á·ü
  • neonatal
    ½Å»ý¾Æ-
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æµ¿Á¾¸é¿ªÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
  • neonatal asphyxia
    ½Å»ý¾ÆÁú½Ä
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal blennorrhea
    °«³­¾Ö°í¸§´«¹°, ½Å»ý¾Æ³ó·ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • neonatal death rate
    ½Å»ý¾Æ»ç¸Á·ü
  • neonatal diarrhea
    ½Å»ý¾Æ¼³»ç
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
  • neonatal hair loss
    ½Å»ý¾ÆÅ»¸ð
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
  • neonatal infection
    ½Å»ý¾Æ°¨¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄ°íÇ÷¾Ð
  • venous blood
    Á¤¸ÆÇ÷¾×, Á¤¸ÆÇÇ
  • central venous pressure
    Áß½ÉÁ¤¸Æ¾Ð
  • venous pressure
    Á¤¸Æ¾Ð
  • neonatal intensive care center
    ½Å»ý¾ÆÁýÁßÄ¡·á½Ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • hypertension
    °íÇ÷¾Ð
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
  • ocular hypertension
    °í¾È¾ÐÁõ
  • portal hypertension
    ¹®¸Æ°íÇ÷¾Ð
  • pregnancy-induced hypertension
    ÀӽŰíÇ÷¾Ð
  • renovascular hypertension
    ÄáÆÏÇ÷°ü°íÇ÷¾Ð, ½ÅÀåÇ÷°ü°íÇ÷¾Ð
  • sinusoidal hypertension
    ±¼Ç÷°ü°íÇ÷¾Ð
  • neonatal infection
    °«³­¾Ö°¨¿°, ½Å»ý¾Æ°¨¿°
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄ°íÇ÷¾Ð
  • accelerated hypertension
    °¡¼Ó°íÇ÷¾Ð
  • adrenal hypertension
    ºÎ½Å°íÇ÷¾Ð
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
  • neonatal asphyxia
    ½Å»ý¾ÆÁú½Ä
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • borderline hypertension
    °æ°è°íÇ÷¾Ð
  • neonatal blennorrhea
    °«³­¾Ö°í¸§´«¹°
  • neonatal intensive care center
    ½Å»ý¾ÆÁýÁßÄ¡·á½Ç
  • diastolic hypertension
    È®Àå±â°íÇ÷¾Ð
  • neonatal death
    ½Å»ý¾Æ»ç¸Á, ¿µ¾Æ»ç
  • neonatal diarrhea
    ½Å»ý¾Æ¼³»ç
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü
  • essential hypertension
    º»Å°íÇ÷¾Ð
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anomalous pulmonary venous connection
    ÆóÁ¤¸Æ¿¬°áÀÌ»ó.
  • anomalous pulmonary venous drainage
    ÆóÁ¤¸ÆÈ¯·ù(øËð¡Øæü½êü)ÀÌ»ó.
  • anomalous pulmonary venous drainage
    ÆóÁ¤¸ÆÈ¯·ù(̰?ËÎÌ·Ëô)ÀÌ»ó.
  • anomalous pulmonary venous return
    ÆóÁ¤¸ÆÈ¯·ùÀÌ»ó.
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â (¡­øÍáð).
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â(øËð¡ØæøÍáð)
  • primary pulmonary hypertension
    ¿ø¹ß(¼º) Æó°íÇ÷¾ÐÁõ(¡­øËÍÔúìäâñø).
  • primary pulmonary hypertension
    ¿ø¹ß(¼º) Æó°íÇ÷¾ÐÁõ(ê«Û¡(àõ) øËÍÔúìäâñø)
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, Æó°íÇ÷¾ÐÁõ.
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð(øËÔÑØæÍÔúìäâ), Æó°íÇ÷¾ÐÁõ(øËÍÔúìäâñø)
  • Jugular venous pressure
    °æÁ¤¸Æ¾Ð·Â(Ìòð¡ØæäâÕô)
  • VAD => venous admixture
    Á¤¸ÆÇ÷È¥ÇÕ
  • anomalies of systemic venous return
    ´ëÁ¤¸ÆÈ¯·ù(ÓÞð¡Øæü½êü)ÀÌ»ó.
  • anomalies of systemic venous return
    ´ëÁ¤¸ÆÈ¯·ù(ËÀ?ËÎÌ·Ëô)ÀÌ»ó.
  • anterior external vertebral venous plexus
    ¾Õ¹Ù±ùôÁÖÁ¤¸Æ¾ó±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary pulmonary hypertension
    ¿ø¹ß(¼º) Æó°íÇ÷¾ÐÁõ(¡­øËÍÔúìäâñø).
  • primary pulmonary hypertension
    ¿ø¹ß(¼º) Æó°íÇ÷¾ÐÁõ(ê«Û¡(àõ) øËÍÔúìäâñø)
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, Æó°íÇ÷¾ÐÁõ.
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð(øËÔÑØæÍÔúìäâ), Æó°íÇ÷¾ÐÁõ(øËÍÔúìäâñø)
  • anomalous pulmonary venous connection
    ÆóÁ¤¸Æ¿¬°áÀÌ»ó.
  • anomalous pulmonary venous drainage
    ÆóÁ¤¸ÆÈ¯·ù(øËð¡Øæü½êü)ÀÌ»ó.
  • anomalous pulmonary venous drainage
    ÆóÁ¤¸ÆÈ¯·ù(̰?ËÎÌ·Ëô)ÀÌ»ó.
  • anomalous pulmonary venous return
    ÆóÁ¤¸ÆÈ¯·ùÀÌ»ó.
  • partial anomalous pulmonary venous return
    ºÎºÐÀû ÆóÁ¤¸ÆÈ¯·ùÀÌ»ó(Ý»ÝÂîÜ øËð¡Øæü½êüì¶ßÈ)
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â (¡­øÍáð).
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â(øËð¡ØæøÍáð)
  • total anomalous pulmonary venous connection
    ÀüÆóÁ¤¸Æ¿¬°áÀÌ»ó(îïøËð¡ØæææÌ¿ì¶ßÈ).
  • total anomalous pulmonary venous connection
    ÀüÆóÁ¤¸Æ¿¬°áÀÌ»ó(îïøËð¡ØæææÌ¿ì¶ßÈ)
  • total anomalous pulmonary venous return
    Àü<ÃÑ>ÆóÁ¤¸ÆÈ¯·ùÀÌ»ó(îï<õÅ>øËð¡ Øæü½êüì¶ßÈ)
  • orifice of pulmonary trunk ; pulmonary ostium ³ª ostium trunci pulmonalis
    Æóµ¿¸Æ±¸¸Û, Æóµ¿¸Æ±¸.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Neonatal period
    ½Å»ý¾Æ±â
    [¿¾ ¿ë¾î] ½Å»ý¾Æ±â
  • Neonatal line
    ù¼ºÀå¼±
    [¿¾ ¿ë¾î] ½Å»ý¼±
  • Thoracic pulmonary branches
    °¡½¿ÇãÆÄ°¡Áö
    [¿¾ ¿ë¾î] ÈäÆóÁö
  • Right inferior pulmonary vein
    ¾Æ·¡¿À¸¥ÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ¿ìÇÏÆóÁ¤¸Æ
  • Left inferior pulmonary vein
    ¾Æ·¡¿ÞÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ÁÂÇÏÆóÁ¤¸Æ
  • Right pulmonary artery
    ¿À¸¥ÇãÆÄµ¿¸Æ
    [¿¾ ¿ë¾î] ¿ìÆóµ¿¸Æ
  • Common pulmonary vein
    ¿ÂÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ÃÑÆóÁ¤¸Æ
  • Left pulmonary artery
    ¿ÞÇãÆÄµ¿¸Æ
    [¿¾ ¿ë¾î] ÁÂÆóµ¿¸Æ
  • Right superior pulmonary vein
    À§¿À¸¥ÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ¿ì»óÆóÁ¤¸Æ
  • Left superior pulmonary veins
    À§¿ÞÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] Á»óÆóÁ¤¸Æ
  • Secondary pulmonary lobule
    ÀÌÂ÷ÇãÆÄ¼Ò¿±
    [¿¾ ¿ë¾î] ÀÌÂ÷Æó¼Ò¿±
  • Primary pulmonary lobule
    ÀÏÂ÷ÇãÆÄ¼Ò¿±
    [¿¾ ¿ë¾î] ÀÏÂ÷Æó¼Ò¿±
  • Pulmonary branches
    ÇãÆÄ°¡Áö
    [¿¾ ¿ë¾î] ÆóÁö
  • Pulmonary groove
    ÇãÆÄ°í¶û
    [¿¾ ¿ë¾î] Æó±¸
  • Pulmonary alveolus
    ÇãÆÄ²Ê¸® [ÆóÆ÷]
    [¿¾ ¿ë¾î] ÆóÆ÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pulmonary amebiasis
    Æó¾Æ¸Þ¹ÙÁõ
  • pulmonary ascariasis
    ÆóÈ¸ÃæÁõ
  • pulmonary echinococcosis
    ÆóÆ÷ÃæÁõ
  • pulmonary hydatid cyst
    ÆóÆ÷Ãæ³¶
  • pulmonary paragonimiasis
    ÆóÈíÃæÁõ
  • pulmonary schistosomiasis
    ÆóÁÖÇ÷ÈíÃæÁõ
  • pulmonary strongyloidiasis
    ÆóºÐ¼±ÃæÁõ
  • tropical pulmonary eosinophilia
    ¿­´ëÆóÈ£»ê±¸Áõ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • renal hypertension
    ½Å°íÇ÷¾Ð(ãìÍÔúìäâ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anomalous pulmonary venous return
    ÆóÁ¤¸ÆÈ¯·ùÀÌ»ó
  • neonatal
    ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal jaundice
    ½Å»ý¾ÆÈ²´Þ
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á(·ü)
  • central venous pressure
    Áß½ÉÁ¤¸Æ¾Ð
  • essential hypertension
    º»Å¼º°íÇ÷¾Ð
  • hypertension
    °íÇ÷¾ÐÁõ, ±äÀåÇ×ÁøÁõ
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ, ¹®¸Æ°íÇ÷¾Ð
  • primary hypertension
    ¿ø¹ß(¼º)°íÇ÷¾ÐÁõ
  • renal hypertension
    ½Å¼º°íÇ÷¾Ð
  • renovascular hypertension
    ½ÅÇ÷°ü¼º°íÇ÷¾Ð
  • splenoportal hypertension
    ºñ¹®¸Æ¼º°íÇ÷¾ÐÁõ
  • venous
    Á¤¸Æ(¼º)ÀÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
PVC peripheral venous catheterization; persistent vaginal cornification; polyvinyl chloride; postvoiding...
IPH idiopathic portal hypertension; idiopathic pulmonary hemosiderosis; idiopathic pulmonary hypertensio...
PPH past pertinent history; persistent pulmonary hypertension; phosphopyruvate hydratase; postpartum hem...
PVP penicillin V potassium; peripheral vein plasma; peripheral venous pressure; polyvinylpyrrolidone; po...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
STOP Hypertension Swedish Trial in Old Patients with Hypertension
CT-E PH Chronic thromboembolic pulmonary hypertension
PPHN Persistent Pulmonary Hypertension of the Newborn
PPH Persistent pulmonary hypertension
PPHN Persistent pulmonary hypertension
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pulmonary arterial hypertension
    Æó ¼øÈ¯ ½Â¾Ð
  • pulmonary hypertension
    Æó ¼øÈ¯ ½Â¾Ð, Æó °íÇ÷¾ÐÁõ
  • total anomalous pulmonary venous connection
    ÀüÆó Á¤¸Æ ¿¬°á ÀÌ»ó, ÃÑ Æó Á¤¸Æ ȯ·ù ÀÌ»ó, Æó Á¤¸Æ ¿¬°á ÀÌ»ó
    1. Á¿ìÀÇ ¸ðµç Æó Á¤¸ÆµéÀÌ Á½ɹæ°ú ¿¬°áµÇÁö ¾Ê°í ºñÁ¤»óÀûÀÎ °æ·Î¸¦ °ÅÃÄ Ã¼Á¤¸ÆÀ¸·Î ¿¬°áµÇ´Â °Í. ȯÀÚ°¡ »ýÁ¸Çϱâ À§Çؼ­´Â ¹Ýµå½Ã ½É¹æ Áß°Ý °á¼ÕÁõÀÌ ÀÖ¾î¾ß ÇÏ¸ç Æó Á¤¸ÆÀÌ ¿¬°áµÇ´Â ºÎÀ§¿¡ µû¶ó ½ÉÀå »óºÎÇü
  • pulmonary perfusion scan :

    pulmonary pleura

    Æó ´Á¸·
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð
  • essential hypertension
    º»Å¼º °íÇ÷¾Ð
    1. Ưº°ÇÑ ¿øÀÎÀÌ ¾Ë·ÁÁöÁö ¾ÊÀº °íÇ÷¾ÐÀ» ÀǹÌÇϸç ÀÌ´Â Àüü °íÇ÷¾Ð ȯÀÚÀÇ 85-90£¥¸¦ Â÷ÁöÇÑ´Ù. 2. À¯Àü, Á¤½ÅÀû ½ºÆ®·¹½º, ¿°ºÐÀÇ Áõ°¡ µî Ç÷¾Ð »ó½ÂÀÌ º¹ÇÕÀûÀÎ ¿øÀÎ ÇüÅ·Π³ªÅ¸³­´Ù.
  • hypertension paroxystique
    ºÒ ¹ßÀÛ¼º °íÇ÷¾Ð
  • juvenile hypertension
    ¿¬¼Ò¼º °íÇ÷¾ÐÁõ, ¿¬¼Ò¼º °íÇ÷¾Ð
  • labile hypertension
    ºÒ¾ÈÁ¤¼º °íÇ÷¾Ð
  • nephrogenous hypertension
    ½Å¼º °íÇ÷¾Ð
  • ocular hypertension indicator
    ¾È±¸ °íÇ÷¾Ð ÁöÇ¥
  • orthostatic hypertension
    ±â¸³¼º °íÇ÷¾Ð, ÀÚ¼¼¼º °íÇ÷¾Ð
  • portal hypertension
    ¹®¸Æ¼º °íÇ÷¾Ð, °£¹®¸Æ °íÇ÷¾Ð, ¹®¸Æ¾Ð Ç×ÁøÁõ, ¹®¸Æ °íÇ÷¾Ð
  • primary hypertension
    ¿ø¹ß °íÇ÷¾ÐÁõ, ¿ø¹ß¼º °íÇ÷¾ÐÁõ
  • renal hypertension
    ½Å¼º °íÇ÷¾Ð
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
neonatal pulmonary venous hypertension <radiology> With cardiomegaly, hypoplastic left heart, critical aortic stenosis, cor triatriatum, pulmonary venous atresia, normal heart size, infradiaphragmatic TAPVR
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
systemic venous hypertension Increased pressure in the veins ultimately leading to the right atrium nearly always due to disease of the right heart but occasionally due to blockade of one or both venae cavae.
(05 Mar 2000)
postcapillary pulmonary hypertension <radiology> Heart: LV failure, mitral stenosis, LA myxoma / thrombus, cor triatriatum, Pulmonary veins: congenital stenosis of pulmonary vein origin, mediastinal granulomata and neoplasms, idiopathic pulmonary veno-occlusive disease, anomalous pulmonary venous return
(12 Dec 1998)
precapillary pulmonary hypertension <radiology> Vascular: increased flow (left to right shunts), decreased flow (tetralogy of Fallot), primary pulmonary hypertension, thromboembolic disease, pulmonary arteritides, Pleuropulmonary: emphysema, diffuse lung disease, fibrothorax, chest deformity, hypoventilation, high-altitude pulmonary hypertension
(12 Dec 1998)
primary pulmonary hypertension A condition where there is increased blood pressure in the pulmonary arteries with otherwise normal heart and lungs. The cause is unknown, but there is diffuse narrowing of the pulmonary arteries resulting in increased arteriolar pressures. Secondary heart failure ensues without correction of this problem. There is an increased incidence of this disease in females between the ages of 20 and 40 years. Treatment may include a heart and lung transplant in select cases.
(27 Sep 1997)
pulmonary hypertension <cardiology> Abnormally elevated blood pressure within the pulmonary circuit (pulmonary artery).
Pulmonary hypertension may be secondary to another disease process (VSD, ASD, severe COAD) or occur as a primary disease process known as primary pulmonary hypertension.
(27 Sep 1997)
hypertension, pulmonary High blood pressure in the pulmonary arteries. Normally, the pressure in the pulmonary arteries is low (compared to that in the aorta). Pulmonary hypertension can irrevocably damage the lungs. Pulmonary hypertension is made up of pulmonary for lung, hyper for high, and tension for blood pressure. (in french, the word for blood pressure is tension ).
(12 Dec 1998)
idiopathic pulmonary hypertension <chest medicine> A condition where there is increased blood pressure in the pulmonary arteries with otherwise normal heart and lungs.
The cause is unknown, but there is diffuse narrowing of the pulmonary arteries resulting in increased arteriolar pressures. Secondary heart failure ensues without correction of this problem. There is an increased incidence of this disease in females between the ages of 20 and 40 years. Treatment may include a heart and lung transplant in select cases.
(27 Sep 1997)
total anomalous pulmonary venous return <radiology> (TAPVR) admixture lesion: cyanosis, increased pulmonary blood flow, must have L to R shunt for survival (e.g., atrial septal defect) associated with, atrial septal defect, asplenia
(12 Dec 1998)
total or partial anomalous pulmonary venous connections Connections in which some or all of the pulmonary veins connect to the right atrium or one of its tributaries.
(05 Mar 2000)
accelerated hypertension <cardiology> A severe form of acute hypertension that results in the abrupt rise in the blood pressure (diastolic pressure often over 120 mmHg). If left untreated, malignant hypertension can cause damage to the blood vessels in the eye, kidneys, brain and heart. Complications include stroke, heart attack, blindness and renal failure.
Symptoms include headache, blurred vision, nausea, vomiting and lethargy. Neurologic symptoms are also a common finding. Malignant hypertension occurs more commonly in males, African Americans and those with a history for hypertension.
(27 Sep 1997)
adrenal hypertension Hypertension due to an adrenal medullary pheochromocytoma or to hyperactivity or functioning tumour of the adrenal cortex.
(05 Mar 2000)
benign hypertension Hypertension that runs a relatively long and symptomless course.
(05 Mar 2000)
borderline hypertension By consensus, that blood pressure zone between highest acceptable "normal" blood pressure and hypertensive blood pressure. The Framingham Heart Study defines this as pressures between 140 and 160 mm Hg systolic and 90 and 95 mm Hg diastolic.
(05 Mar 2000)
pale hypertension Hypertension with pallor of the skin, a severe form with pronounced constriction of peripheral vessels.
(05 Mar 2000)
malignant hypertension A severe form of acute hypertension that results in the abrupt rise in the blood pressure (diastolic pressure often over 120 mmHg). If left untreated, malignant hypertension can cause damage to the blood vessels in the eye, kidneys, brain and heart. Complications include stroke, heart attack, blindness and renal failure.
Symptoms include headache, blurred vision, nausea, vomiting and lethargy. Neurologic symptoms are also a common finding. Malignant hypertension occurs more commonly in males, African Americans and those with a history for hypertension.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal
    ½Å»ý¾ÆÀÇ
  • hypertension
    °íÇ÷¾Ð; °úµµ ±äÀå
  • venous
    Á¤¸ÆÀÇ
  • hypertension
    °íÇ÷¾Ð
  • venous
    Á¤¸Æ(¼Ó)ÀÇ;¸ÆÀÌ(ÁٱⰡ)ÀÖ´Â
  • pulmonary
    ÆóÀÇ
  • pulmonary
    ÆóÀÇ;Æó¸¦ ħ¹üÇÏ´Â;Æêº´ÀÇ;Æó¸¦ °¡Áø
  • pulmonary artery
    Æóµ¿¸Æ
  • pulmonary embolism
    Æó»öÀü(½ÉÀå µî¿¡ ÀÖ´ø Ç÷ÀüÀÌ Ç÷¾×À» ÅëÇØ ÆóÀÇ Ç÷°ü¿¡ °É·Á ÀÖ´Â »óÅÂ)
  • pulmonary tuberculosis
    Æó°áÇÙ
  • pulmonary vein
    ÆóÁ¤¸Æ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á